0000950170-23-065108.txt : 20231120 0000950170-23-065108.hdr.sgml : 20231120 20231120162116 ACCESSION NUMBER: 0000950170-23-065108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231117 FILED AS OF DATE: 20231120 DATE AS OF CHANGE: 20231120 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Andersen Jill CENTRAL INDEX KEY: 0001891047 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40703 FILM NUMBER: 231423046 MAIL ADDRESS: STREET 1: 303 WYMAN STREET STREET 2: SUITE 300 CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Invivyd, Inc. CENTRAL INDEX KEY: 0001832038 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 851403134 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: (781) 819-0080 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 178 CITY: WALTHAM STATE: MA ZIP: 02451 FORMER COMPANY: FORMER CONFORMED NAME: Adagio Therapeutics, Inc. DATE OF NAME CHANGE: 20201112 4 1 ownership.xml 4 X0508 4 2023-11-17 0001832038 Invivyd, Inc. IVVD 0001891047 Andersen Jill C/O INVIVYD, INC. 1601 TRAPELO ROAD, SUITE 178 WALTHAM MA 02451 false true false false Chief Legal Officer, Secretary false Stock Option (Right to Buy) 1.44 2023-11-17 4 A false 325000 0.00 A 2033-11-16 Common Stock 325000 325000 D This option vests over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the grant date of November 17, 2023 and the remaining 75% of the shares subject to the option vesting over the subsequent three-year period in substantially equal monthly installments at a rate of 1/48th of the total shares subject to the option each month, subject to the Reporting Person's continuous service as of each vesting date. /s/ Jill Andersen 2023-11-20